Pharma Focus Asia

Ultima Genomics Collaborates with Genome Insight

Monday, April 10, 2023

Ultima Genomics and Genome Insight have signed an agreement to collaborate to bring affordable whole genome sequencing solutions to cancer patients.

As part of the agreement, Genome Insight will join the early access programme for Ultima’s high-throughput NGS instrument platform, the UG 100TM, and develop an optimised version of its whole genome bioinformatics solution for Ultima’s sequencing technology. The combination of Genome Insight’s proprietary bioinformatics with Ultima’s low-cost sequencing will make whole genome sequencing an affordable reality for cancer patients.

This partnership with Ultima will bring affordable whole genome sequencing to cancer patients. The ability to analyse the entire genome at a low cost is a game-changer in cancer treatment. This collaboration is an important step towards the vision of using whole genome sequencing to improve patient outcomes.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024